* Cross Country Healthcare Inc CCRN.OQ CCRN.O is
expected
to show a fall in quarterly revenue when it reports results on
February 21 for the period ending December 31 2023
* The Boca Raton Florida-based company is expected to
report a
35.6% decrease in revenue to $404.424 million from $628.22
million a year ago, according to the mean estimate from 9
analysts, based on LSEG data.The company's guidance on November
1 2023, for the period ended December 31, was for revenue
between 400.00 million and 410.00 million.
* LSEG's mean analyst estimate for Cross Country Healthcare
Inc
is for earnings of 27 cents per share. The company's EPS
guidance on November 1 2023, for the period ended December
31, was between 0.25 and 0.35
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cross
Country
Healthcare Inc is $22.00, above its last closing price
of $17.55.
The company's guidance on November 1 2023 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 400 million and 24
million.The company's guidance on November 1 2023 for the period
ended December 31 was for gross profit margin between 21.5% and
22%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.41 0.41 0.39 Missed -4.2
Jun. 30 2023 0.61 0.61 0.69 Beat 13.3
Mar. 31 2023 0.75 0.75 0.84 Beat 12.4
Dec. 31 2022 0.89 0.89 1.09 Beat 21.9
Sep. 0.96 0.95 1.07 Beat 12.6
30 2022
Jun. 30 2022 1.35 1.35 1.40 Beat 3.8
Mar. 31 2022 1.34 1.31 1.70 Beat 29.3
Dec. 31 2021 1.30 1.24 1.40 Beat 12.6
This summary was machine generated February 19 at 22:54 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)